ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FAB Fusion Antibodies Plc

3.40
-0.05 (-1.45%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -1.45% 3.40 3.30 3.50 3.45 3.40 3.45 337,987 14:17:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0437 -0.78 2.02M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.45p. Over the last year, Fusion Antibodies shares have traded in a share price range of 3.10p to 37.50p.

Fusion Antibodies currently has 59,453,714 shares in issue. The market capitalisation of Fusion Antibodies is £2.02 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -0.78.

Fusion Antibodies Share Discussion Threads

Showing 4026 to 4049 of 4075 messages
Chat Pages: 163  162  161  160  159  158  157  156  155  154  153  152  Older
DateSubjectAuthorDiscuss
02/4/2024
15:00
Just read your last 10 posts, another bot for the filter bin...
troutisout
02/4/2024
14:56
Yep fab considering delisting needs shareholder vote to agree
beatme1
02/4/2024
10:31
They do not have billions of shares
bobaxe1
02/4/2024
09:51
Bought APH , Alliance Pharma plc , growing profitable health care company
blackhorse23
02/4/2024
08:38
Hearing fab want to delist following other pharma stocks
beatme1
22/3/2024
18:56
I agree I bought at 3.73Fully funded and ready for a re-rate
bigjock36
22/3/2024
14:48
No brainier down here
bobaxe1
21/3/2024
13:36
According to the financials we have 10x cash to Mcap surly that is not so ?
bobaxe1
15/3/2024
16:03
Just topped up shows red good price not complaining
bobaxe1
14/3/2024
13:22
https://x.com/fsnantibodies/status/1768264192648171934?s=46&t=KHNNXk1Nw1j5lyzHBSnKag
bobaxe1
07/3/2024
12:19
Looking good, I think they want to take it higher
soultrading
07/3/2024
08:37
Picking up here
bobaxe1
05/3/2024
15:36
Decent 901k buy there ??
bigjock36
03/3/2024
21:16
Some decent news after placing and 7 should not be an issue
bigjock36
01/3/2024
11:19
Nice to see a bit of action back, another assault on 7s please, GLA
lawson27
01/3/2024
11:02
I have, but have been several of the larger buys since last Thursday last week, so been happy with the way the price action has gone...
troutisout
01/3/2024
09:14
Anyone else noticed a regular pattern with this. An immediate sell of a few thousand at the start of the day to weaken the price, and then multiple larger buys throughout the day
ksddw2
27/2/2024
12:33
Agree soultrading-cash roughly 60% of market cap and little snippets, like this am's deal, small as it is, all help and happy to see them them getting a few more over the next year so they can gain traction within the field. What is important here is not the amount but the fact a tiny Belfast company's antibody library is even sufficiently worthwhile that a global diagnostics company, and the US NCI would even be aware of it.
The science must be OK-all it takes is one tiny break....but they will be snapped up soon imo.

cumnor
27/2/2024
11:23
Probably the best time to buy for a while. Funded with anticipated news flow makes the current cap look like an opportunity.Once the placees get their shares we can expect a real ramp. As shard did the book build we can add 6% on to 4p just for their break even price and I bet they want a lot more, as I am aware a chunk are sticky.Director options are 4.25 which implies that they believe the price will be way north of that.Those new or reinvesting have an opportunity to get in at a decent level and with funding sorted it eliminates some risk.
soultrading
27/2/2024
10:31
"Fusion Antibodies (FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announced it has received a first purchase order under the master services agreement (MSA) with a leading diagnostics company details of which were announced on 14 February 2024. FAB said reaching this agreement with a world class diagnostics provider positively reinforces the value to the wider commercial world of Fusion Antibodies’ technologies and capabilities. In this case it is the generation of antibodies in diagnostics products.

Comment: It could be argued that fundamentally FAB is now on track as a recovery situation, with the purchase order and recent funding. Only a rise in the share price is missing."

troutisout
15/2/2024
14:27
behave abbeygale ! prior to the placing their was less shares in issue &

Granted with volume the Sp marched North, so now the prospects of more shares

in issue weakens the "Eps ! giving a lower share value & a realistic value

Due South....The Law of Gravity ?...Every day is a School Day !

dreamtwister
15/2/2024
14:01
I have not fallen for the selling this time round. As I know how quickly it goes back up.
luckyabbeygale
15/2/2024
10:06
Latest broker note

hxxps://wp-allenby-2020.s3.eu-west-2.amazonaws.com/media/2024/02/20240215-Fusion-Antibodies-plc-FAB.L-Allenby-Capital-Update.pdf?c4036=on

gtc1508
14/2/2024
13:13
i notice abbey has got her grannie Knickers on ....lol...(y)
dreamtwister
Chat Pages: 163  162  161  160  159  158  157  156  155  154  153  152  Older